To further investigate the effect of AT-001 on AR activity, glucose homeostasis and adiposity, C57BL/6J mice were subjected to experimental type 2 diabetes, which involved supplementation with HFD for 10 weeks with a single treatment of STZ (75 mg/kg) at 4 weeks into the protocol. Here, AR is linked to type 2 diabetes mellitus.